{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:32:43Z","timestamp":1790292763988,"version":"4.1.0"},"publisher-location":"Chichester, UK","update-to":[{"DOI":"10.1002\/14651858.cd006754","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T00:00:00Z","timestamp":1425340800000},"record-id":"32313"},{"DOI":"10.1002\/14651858.cd006754.pub2","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T00:00:00Z","timestamp":1425340800000},"record-id":"32315"}],"reference-count":95,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006754.pub3","type":"reference-entry","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T11:41:36Z","timestamp":1425382896000},"source":"Crossref","is-referenced-by-count":28,"title":["Anticonvulsants for cocaine dependence"],"prefix":"10.1002","author":[{"given":"Silvia","family":"Minozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Davoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anelise ARL","family":"Lima Reisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Pani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Silva de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo GO","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Vecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,3]]},"reference":[{"key":"10.1002\/14651858.CD006754.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1360-0443.2005.00983.x","article-title":"A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence","volume":"100(Suppl 1)","author":"Berger","year":"2005","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD006754.pub3-BIB2|cit2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1360-0443.2005.00983.x","article-title":"A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence","volume":"100(Suppl 1)","author":"Berger","year":"2005","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD006754.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2005.07.009","article-title":"A randomised placebo-controlled trial of gabapentin for cocaine dependence","volume":"81(3)","author":"Bisaga","year":"2006","journal-title":"Drug and alcohol Dependence"},{"key":"10.1002\/14651858.CD006754.pub3-BIB4|cit4","first-page":"191","article-title":"Impact of Desipramine or Carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings","volume":"13(4)","author":"Campbell","year":"1994","journal-title":"Journal of Addictive Diseases"},{"key":"10.1002\/14651858.CD006754.pub3-BIB5|cit5","first-page":"191","article-title":"Impact of Desipramine or Carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings","volume":"13(49","author":"Campbell","year":"1994","journal-title":"Journal of Addictive Diseases"},{"key":"10.1002\/14651858.CD006754.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1521-0391.2003.tb00610.x","article-title":"Comparison of desipramine or carbamazepine to placebo for crack cocaine dependent patients","volume":"12","author":"Campbell","year":"2003","journal-title":"Am J Addict"},{"key":"10.1002\/14651858.CD006754.pub3-BIB7|cit7","series-title":"NIDA Research monograph","article-title":"Gender differences in pharmacologic treatment for cocaine dependence.","author":"Campbell","year":"1999"},{"key":"10.1002\/14651858.CD006754.pub3-BIB8|cit8","series-title":"NIDA Research Monograph","first-page":"147","article-title":"Efficacy and compliance with carbamazepine and desipramine versus placebo for cocaine abusers","author":"Campbell","year":"1996"},{"key":"10.1002\/14651858.CD006754.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1521-0391.2003.tb00610.x","article-title":"Comparison of desipramine or carbamazepine to placebo for crack cocaine dependent patients","volume":"12","author":"Campbell","year":"2003","journal-title":"Am J Addict"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0376-8716(95)01102-5","article-title":"Carbamazepine treatment for cocaine dependence","volume":"38","author":"Cornish","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD006754.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0009-9236(96)90116-2","article-title":"Phentoin in the treatment of cocaine abuse: a double blind study","volume":"59","author":"Crosby","year":"1996","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD006754.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1046\/j.1360-0443.2003.00544.x","article-title":"Tiagabine increases cocaine-free urine in cocaine-dependent methadone-treated patients: results of a randomised pilot study","volume":"98","author":"Gonzalez","year":"2003","journal-title":"Addiction"},{"issue":"11","key":"10.1002\/14651858.CD006754.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1046\/j.1360-0443.2003.00544.x","article-title":"Tiagabine increases cocaine-free urine in cocaine-dependent methadone-treated patients: results of a randomised pilot study","volume":"98","author":"Gonzalez","year":"2003","journal-title":"Addiction"},{"issue":"1","key":"10.1002\/14651858.CD006754.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.07.003","article-title":"Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients","volume":"87","author":"Gonzalez","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1002\/14651858.CD006754.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2006.07.003","article-title":"Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients","volume":"87","author":"Gonzalez","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB16|cit16","first-page":"345","article-title":"Daily monitored cardiovascular effects of Carbamazepine in chronic crack cocaine use","volume":"27","author":"Halikas","year":"1991","journal-title":"Psychopharmacological Bullettin"},{"issue":"1","key":"10.1002\/14651858.CD006754.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0009-9236(97)90155-7","article-title":"A randomised double-blind study of carbamazepine in the treatment of cocaine abuse","volume":"62","author":"Halikas","year":"1997","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB18|cit18","first-page":"345","article-title":"Daily monitored cardiovascular effects of Carbamazepine in chronic crack cocaine use","volume":"27","author":"Halikas","year":"1991","journal-title":"Psychopharmacological Bullettin"},{"issue":"1","key":"10.1002\/14651858.CD006754.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0009-9236(97)90155-7","article-title":"A randomised double-blind study of carbamazepine in the treatment of cocaine abuse","volume":"62","author":"Halikas","year":"1997","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampan","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD006754.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0376-8716(95)01165-3","article-title":"Carbamazepine and cocaine-cue reactivity","volume":"39","author":"Hersh","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0376-8716(95)01100-D","article-title":"Carbamazepine treatment of cocaine dependence: a placebo-controlled trial","volume":"38","author":"Kranzler","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0376-8716(95)01101-4","article-title":"Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence","volume":"38","author":"Montoya","year":"1995","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006754.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1360-0443.2005.00990.x","article-title":"A placebo-controlled screening trial of olanzapine, valproate and coenzyme Q10\/L-carnitine for the treatment of cocaine dependence","volume":"100","author":"Reid","year":"2005","journal-title":"Addiction"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0376-8716(98)00140-9","article-title":"Effects of phenytoin on cocaine self-administration in humans","volume":"53","author":"Sofuoglu","year":"1999","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006754.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1360-0443.2005.00992.x","article-title":"A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments","volume":"100","author":"Winhusen","year":"2005","journal-title":"Addiction"},{"issue":"6","key":"10.1002\/14651858.CD006754.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10550490600998476","article-title":"Outcome predictors in cocaine dependence treatment trials","volume":"15","author":"Ahmadi","year":"2006","journal-title":"The American journal of Addiction Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB28|cit28","first-page":"276","article-title":"Carbamazepine in the teratment of cocaine dependence: subtyping by affective disorders","volume":"10","author":"Brady","year":"2002","journal-title":"Experimental and clinical pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006754.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4088\/JCP.v64n0213","article-title":"Lamotrigine in patients with bipolar disorder and cocaine dependence","volume":"64","author":"Brown","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD006754.pub3-BIB30|cit30","series-title":"Drud and Alcohol Dependence. Sixty-Thrid Annual Scientific Meetind Scottsdale, Arizona","article-title":"Does worse predict better? Characteristics and outcomes of volunteers for a medication trial or Psychosocial trial","author":"Campbell","year":"2001"},{"key":"10.1002\/14651858.CD006754.pub3-BIB31|cit31","series-title":"NIDA Research Monograph","article-title":"An analysis of factors influencing subject participation in a trial of carbamazepine for cocaine dependence treatment","author":"Cornish","year":"1995"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006754.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1360-0443.2005.00986.x","article-title":"Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence","volume":"100","author":"Elkashef","year":"2005","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD006754.pub3-BIB33|cit33","series-title":"NIDA Research Monograph","first-page":"137","article-title":"Carbamazepine (CBS) does not alter cocaine self-administration in human cocaine addicts","author":"Gorelick","year":"1994"},{"issue":"8638","key":"10.1002\/14651858.CD006754.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(89)91660-7","article-title":"Carbamazepine for cocaine addiction","volume":"1","author":"Halikas","year":"1989","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD006754.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/clpt.1991.107","article-title":"Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short term, double blind cross over design","volume":"50","author":"Halikas","year":"1991","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1002\/14651858.CD006754.pub3-BIB36|cit36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.drugalcdep.2005.03.006","article-title":"Smoked cocaine discrimination in humans: effects of gabapentin","volume":"80","author":"Haney","year":"2005","journal-title":"Drug and Alcohol dependence"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.drugalcdep.2003.10.015","article-title":"Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans","volume":"73","author":"Hart","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"2-3","key":"10.1002\/14651858.CD006754.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.drugalcdep.2006.05.028","article-title":"Smoked cocaine self-administration by humans is not reduced by large gabapentin maintenance doses","volume":"86","author":"Hart","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD006754.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF02244565","article-title":"Effects of carbamazepine on acute responses to smoked cocaine-base in human cocaine users","volume":"104","author":"Hatsukami","year":"1991","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD006754.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00023210-200519100-00005","article-title":"Recent advances in the development of treatments for alcohol and cocaine dependence","volume":"19","author":"Johnson","year":"2005","journal-title":"CNS Drugs"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006754.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1360-0443.2005.00987.x","article-title":"Cocaine rapid efficacy screening trials (CREST): lessons learned","volume":"100","author":"Kampman","year":"2005","journal-title":"Addiction"},{"key":"10.1002\/14651858.CD006754.pub3-BIB42|cit42","series-title":"NIDA Research Monograph","article-title":"Carbamazepine treatment of cocaine dependence in methadone maintenance patient with dual opiate-cocaine addiction","author":"Kuhn","year":"1989"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006754.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1360-0443.2005.00988.x","article-title":"Cocaine rapid efficacy screening trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence","volume":"100","author":"Leiderman","year":"2005","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/14651858.CD006754.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.addbeh.2006.05.007","article-title":"Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study","volume":"32","author":"Salloum","year":"2007","journal-title":"Addictive Behaviors"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.pbb.2005.10.013","article-title":"Tiagabine affects the subjective response to cocaine in humans","volume":"82","author":"Sofuoglu","year":"2005","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1002\/14651858.CD006754.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.yco.0000165596.98552.02","article-title":"Pharmacotherapy and other treatments for cocaine abuse and dependence","volume":"18","author":"Vocci","year":"2005","journal-title":"Current Opinion in Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006754.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1081\/ADA-100100590","article-title":"Effects of lamotrigine on behavioral and cardiovascular responses to cocaine in human subjects","volume":"26","author":"Winther","year":"2000","journal-title":"American journal Drug and Alcohol Abuse"},{"issue":"7","key":"10.1002\/14651858.CD006754.pub3-BIB48|cit48","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1358\/dot.2004.40.7.850478","article-title":"Anticonvulsant drugs in the treatment of substance withdrawal","volume":"40","author":"Zullino","year":"2004","journal-title":"Drugs of Today"},{"key":"10.1002\/14651858.CD006754.pub3-BIB49|cit49","unstructured":"Effectiveness of tiagabine for cocaine dependence in methadone maintenance individuals Ongoing study"},{"key":"10.1002\/14651858.CD006754.pub3-BIB50|cit50","unstructured":"Effectiveness of topiramate in treating cocaine dependent individuals Ongoing study"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB51|cit51","article-title":"Antipsychotic medication for cocaine dependence","author":"Amato","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006754.pub3-BIB52|cit52","first-page":"461","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psichiatry"},{"issue":"2","key":"10.1002\/14651858.CD006754.pub3-BIB53|cit53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002130050937","article-title":"Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats","volume":"143","author":"Campbell","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD006754.pub3-BIB54|cit54","doi-asserted-by":"crossref","first-page":"156-63; discuss","DOI":"10.1111\/j.1749-6632.1993.tb26345.x","article-title":"The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care","volume":"703","author":"Chalmers","year":"1993","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"10.1002\/14651858.CD006754.pub3-BIB55|cit55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00952999709001686","article-title":"Characteristics and pre-treatment behaviours of clients entering drug abuse treatment: 1969 to 1993","volume":"23","author":"Craddok","year":"1997","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"4","key":"10.1002\/14651858.CD006754.pub3-BIB56|cit56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1300\/J069v10n04_02","article-title":"Pharmacotherapeutic interventions for cocaine abuse: present practices and future directions","volume":"10","author":"Crosby","year":"1991","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006754.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568026053386962","article-title":"Mechanisms of action of antiepileptic drugs.","volume":"5","author":"Czapinski","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"10.1002\/14651858.CD006754.pub3-BIB58|cit58","unstructured":"Davoli M Pasqualini F Belleudi V Bargagli AM Perucci CA Changing pattern of drug abuse among patients entering treatment in Lazio, Italy, 1996-2003: transition from heroin to cocaine use European Addiction Research."},{"issue":"14","key":"10.1002\/14651858.CD006754.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Chiara","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1002\/14651858.CD006754.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0893-133X(99)00079-2","article-title":"PET Measures of Amphetamine-Induced Dopamine Release in Ventral versus Dorsal Striatum","volume":"21","author":"Drevets","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006754.pub3-BIB61|cit61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","article-title":"Amphetamine-Induced Dopamine Release in Human Ventral Striatum Correlates with Euphoria","volume":"49","author":"Drevets","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1002\/14651858.CD006754.pub3-BIB62|cit62","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1002\/14651858.CD006754.pub3-BIB63|cit63","unstructured":"The state of the drugs problem in the European Union and Norway European Monitoring Centre for Drug and Drug Abuse, Luxemburg 2006"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB64|cit64","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","author":"Faggiano","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD006754.pub3-BIB65|cit65","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00004714-199712000-00008","article-title":"Replacement medication for cocaine dependence","volume":"17","author":"Grabowski","year":"1997","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006754.pub3-BIB66|cit66","volume-title":"Assessment Manual for Psychopharmacology. Publication ADM 76-338","author":"Guy","year":"1976"},{"issue":"1","key":"10.1002\/14651858.CD006754.pub3-BIB67|cit67","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"British Journal Med Psycol"},{"issue":"4","key":"10.1002\/14651858.CD006754.pub3-BIB68|cit68","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness.","volume":"6","author":"Hamilton","year":"1967","journal-title":"British Journal Soc Clin Psychol"},{"issue":"7","key":"10.1002\/14651858.CD006754.pub3-BIB69|cit69","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archpsyc.1994.03950070060011","article-title":"Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence","volume":"51","author":"Higgins","year":"1994","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006754.pub3-BIB70|cit70","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] The Cochrane Library 2007","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD006754.pub3-BIB71|cit71","volume-title":"A Brief History of Cocaine","author":"Karch","year":"2006"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB72|cit72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003023.pub2","article-title":"Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders","author":"Knapp","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB73|cit73","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1176\/jnp.9.3.482","article-title":"The neurobiology of drug addiction","volume":"9","author":"Koob","year":"1997","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"1","key":"10.1002\/14651858.CD006754.pub3-BIB74|cit74","first-page":"58","article-title":"A review of pharmacotherapies for substance abuse","volume":"5","author":"Kosten","year":"1996","journal-title":"American Journal of Addiction"},{"issue":"2","key":"10.1002\/14651858.CD006754.pub3-BIB75|cit75","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0022-3565(24)34966-3","article-title":"The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats","volume":"290","author":"Kushner","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD006754.pub3-BIB76|cit76","first-page":"RA1","article-title":"Targets for antiepileptic drugs in the synapse.","volume":"13","author":"Landmark","year":"2007","journal-title":"Med Sci Monit. 2007 Jan;13(1)"},{"issue":"2","key":"10.1002\/14651858.CD006754.pub3-BIB77|cit77","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002950","article-title":"Antidepressants for cocaine dependence","author":"Lima","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006754.pub3-BIB78|cit78","article-title":"Carbamazepine for cocaine dependence","author":"Lima Reisser","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006754.pub3-BIB79|cit79","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB80|cit80","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"Journal Substance Abuse Treatment"},{"issue":"9128","key":"10.1002\/14651858.CD006754.pub3-BIB81|cit81","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"9193","key":"10.1002\/14651858.CD006754.pub3-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of metananalysis of randomised controlled trials: the QUORUM statement","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006754.pub3-BIB83|cit83","unstructured":"Substance Abuse and Mental Health Services Administration (2005) Overview of Findings from the 2004 National Survey on Drug Use and Health (Office of Applied Studies, NSDUH Series H-27, DHHS Publication No. SMA 05-4061). Rockville, MD"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB84|cit84","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005063.pub2","article-title":"Benzodiazepines for alcohol withdrawal","author":"Ntais","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006754.pub3-BIB85|cit85","first-page":"621","article-title":"Drug addiction and drug abuse","volume-title":"The pharmacological basis of Therapeutics","author":"O'Brian","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB86|cit86","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005064.pub2","article-title":"Anticonvulsants for the management of alcohol withdrawal","author":"Polycarpou","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD006754.pub3-BIB87|cit87","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD006754.pub3-BIB88|cit88","first-page":"580","article-title":"Recreational drug consumers: who seek treatment? European","volume":"15","author":"Siliquini","year":"2005","journal-title":"Journal of Public Health"},{"issue":"2","key":"10.1002\/14651858.CD006754.pub3-BIB89|cit89","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003352","article-title":"Dopamine agonists for cocaine dependence","author":"Soares","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006754.pub3-BIB90|cit90","series-title":"Annual Meeting of the American Psychiatric Association","article-title":"In search of a universal drug craving scale","author":"Somoza","year":"1995"},{"key":"10.1002\/14651858.CD006754.pub3-BIB91|cit91","volume-title":"Preventing AIDS in drug abusers and their sexual partners","author":"Sorensen","year":"1991"},{"key":"10.1002\/14651858.CD006754.pub3-BIB92|cit92","volume-title":"State-Trate Anxiety Inventory","author":"Spielberg","year":"1983"},{"issue":"15","key":"10.1002\/14651858.CD006754.pub3-BIB93|cit93","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0025-7753(01)72184-7","article-title":"Change in health-related problems of cocaine consumption in Catalonia, Spain.","volume":"117","author":"Suelves","year":"2001","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"10.1002\/14651858.CD006754.pub3-BIB94|cit94","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0376-8716(03)00013-9","article-title":"Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia","volume":"70","author":"Topp","year":"2003","journal-title":"Drug & Alcohol Dependence"},{"issue":"10","key":"10.1002\/14651858.CD006754.pub3-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1172\/JCI18533","article-title":"The addicted human brain: Insights for imaging studies","volume":"111","author":"Volkow","year":"2003","journal-title":"Journal of Clinical Investigation"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006754.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T17:19:10Z","timestamp":1747761550000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006754.pub3"}},"subtitle":[],"editor":[{"given":"Silvia","family":"Minozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,3]]},"references-count":95,"aliases":["10.1002\/14651858.cd006754.pub4"],"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006754.pub3","relation":{},"subject":[],"published":{"date-parts":[[2015,3,3]]}}}